Skip to main content
. 2024 Oct 3;15:8578. doi: 10.1038/s41467-024-52379-2

Fig. 8. Transgenic overexpression of hepatic Fgf21 or administration of rmFGF21 alleviated hepatic I/R injury in steatotic livers.

Fig. 8

a The steatotic mouse models underwent intravenous injection of rmFGF21 (0.5 mg/kg) or tail vein injection of AAV8-hAAT-Fgf21 before I/R injury. b 15-HETE content in the livers from each group 6 h after reperfusion (n = 4, per group). c Serum ALT and AST 6 h after reperfusion (n = 5, per group). d H&E staining, ROS staining and TUNEL staining and quantification results of liver sections from each group 6 h after reperfusion (n = 5, per group). e Quantification assessment of infiltrating CD11b+ and MPO+ cells in the livers of each group (n = 5, per group). f The general schematic diagram. LT, liver transplantation; AA, arachidonic acid. I/R, ischemia/reperfusion; HFD, high-fat diet; ALT, alanine aminotransferase; AST, aspartate aminotransferase; HE, hematoxylin and eosin; ROS, reactive oxygen species; DHE, dihydroethidium; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; MPO, cytosolic myeloperoxidase. Two-tailed t-test. Statistic data are presented as the mean ± SD, error bars represent the means of at least three independent experiments. p values are shown on the graphs, p < 0.05 was considered statistically significant. Source data are provided as a Source Data file. Figure 8a, f created with BioRender. com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license (https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en).